LDB
MBOT icon

Lee, Danner & Bass’s Microbot Medical MBOT Stock Holding History

Lee, Danner & Bass’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,250
Closed -$20.5K – 250
2025
Q4 		$20.5K Sell
10,250
-386
-4% -$914 ﹤0.01% 234
2025
Q3 		$32.4K Hold
10,636
– – ﹤0.01% 233
2025
Q2 		$26.8K Hold
10,636
– – ﹤0.01% 223
2025
Q1 		$16.1K Buy
10,636
+10,536
+10,536% +$18.6K ﹤0.01% 220
2024
Q4 		$112 Buy
+100
New +$98 ﹤0.01% 742

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Lee, Danner & Bass's MBOT Position: Q1 2026 in Review

Lee, Danner & Bass sold out of Microbot Medical (MBOT) in Q1 2026, closing a stake of 10,250 shares — an estimated $20.5K sold.

Lee, Danner & Bass first reported a position in MBOT in Q4 2024 and held it in 5 quarters. The position peaked at $32.4K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Lee, Danner & Bass reported no remaining Microbot Medical position as of Q1 2026 after selling out during the quarter.
  • Lee, Danner & Bass sold 10,250 Microbot Medical shares in Q1 2026, an estimated $20.5K.
  • Lee, Danner & Bass first reported a position in Microbot Medical in Q4 2024 and held it in 5 quarters.
  • Lee, Danner & Bass's Microbot Medical position peaked at $32.4K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Lee, Danner & Bass's 13F filing for Q1 2026, filed 28 Apr 2026.